SIREN : 381309277
EURO SYMBIOSE is a French company founded 35 years ago, specialized in the sector Formation continue d'adultes. Based in CARQUEFOU (44470), this company of category ETI shows in 2024 a revenue of 13.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13 530 238 € | 6 590 916 € | 5 568 732 € | 5 009 717 € | 2 827 011 € | 4 931 098 € | 5 879 862 € | 4 365 275 € |
| Net income | 1 918 470 € | 1 047 616 € | 892 785 € | 850 058 € | 133 876 € | 519 518 € | 775 720 € | 447 191 € |
| EBITDA | 2 270 164 € | 1 311 122 € | 1 229 866 € | 1 184 093 € | 222 407 € | 790 637 € | 1 186 183 € | 644 627 € |
| Net margin | 14.2% | 15.9% | 16.0% | 17.0% | 4.7% | 10.5% | 13.2% | 10.2% |
In 2024, EURO SYMBIOSE achieves revenue of 13.5 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +15.2%. Vs 2023, growth of +105% (6.6 M€ -> 13.5 M€). After deducting consumption (-400 €), gross margin stands at 13.5 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 2.3 M€, representing 16.8% of revenue. Warning negative scissor effect: despite revenue change (+105%), EBITDA varies by +73%, reducing margin by 3.1 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.9 M€, i.e. 14.2% of revenue. This profit can be retained or distributed to shareholders.
13 530 238 €
13 530 638 €
2 270 164 €
2 270 132 €
1 918 470 €
16.8%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 14.1% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.0%
59.303%
14.122%
0.0
21.7%
In 2024, the debt ratio of EURO SYMBIOSE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of EURO SYMBIOSE (59.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of EURO SYMBIOSE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 243.49. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.1x. Coverage is limited: any activity downturn would jeopardize interest payments.
243.487
1.098
In 2024, the liquidity ratio of EURO SYMBIOSE (243.49) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of EURO SYMBIOSE (1.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 96 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 119 days. Favorable situation: supplier credit is longer than customer credit by 23 days. Overall, WCR represents 275 days of revenue, i.e. 10.4 M€ to permanently finance. Over 2016-2024, WCR increased by +1728%, requiring additional financing.
10 351 444 €
96 j
119 j
0 j
275 j
Based on 134 transactions of similar company sales (all years), the value of EURO SYMBIOSE is estimated at 5 038 811 € (range 1 796 288€ - 15 331 813€). With an EBITDA of 2 270 164€, the sector multiple of 2.2x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 134 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare EURO SYMBIOSE with other companies in the same sector:
Voir toutes les statistiques du secteur Formation continue d'adultes
The revenue of EURO SYMBIOSE in 2024 is 13.5 M€.
Yes, EURO SYMBIOSE generated a net profit of 1.9 M€ in 2024.
The headquarters of EURO SYMBIOSE is located in CARQUEFOU (44470), in the department Loire-Atlantique.
The tax return of EURO SYMBIOSE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
EURO SYMBIOSE operates in the sector Formation continue d'adultes (NAF code 85.59A). See the 'Sector positioning' section above to compare the company with its competitors.